StockData
SIGANasdaqPharmaceutical PreparationsFiscal year ends December 31

SIGA TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.14−0.03 (-0.95%)

Close on Oct 19, 2026

Market cap
$225.72M
P/E (TTM)
–
Dividend yield
19.11%

SIGA TECHNOLOGIES INC revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Product Sales and Supportive Services [Member]$88.05M$133.33M$130.67M$86.66M$126.80M$115.47M$11.19M$468.92M––93.1%-34.0%
Research and Development [Member]$6.53M$5.39M$9.25M$24.11M$6.87M$9.49M$15.55M$8.14M––6.9%+21.1%
Research and development––––––$15.55M$8.14M$12.27M$14.99M––
Product sales and supportive services––––––$11.19M$468.92M$0$0––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
United States$88.75M$115.74M$118.65M$39.80M$120.66M$122.42M––––93.8%-23.3%
Non-US [Member]$5.82M$22.98M$21.27M$70.97M$13.01M$2.54M––––6.2%-74.7%
Canada$5.82M$737.68K$0$38.88M$13.01M$2.54M––––6.2%+689.1%
Asia Pacific [Member]$0$13.86M$966.63K$14.85M$0$0––––0.0%-100.0%
EMEA [Member]$0$8.38M$20.30M$16.27M$0$0––––0.0%-100.0%
Other [Member]–$0$0$972.80K$0$0––––––

From the segment and revenue-disaggregation notes of Siga Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.